NCT00005033View on ClinicalTrials.gov

Trastuzumab in Treating Patients With Recurrent Osteosarcoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1999

Study Completion Date

August 31, 2004

Conditions
Sarcoma
Interventions
BIOLOGICAL

trastuzumab

PROCEDURE

conventional surgery

Trial Locations (4)

10021

Memorial Sloan-Kettering Cancer Center, New York

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

02115

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

38105-2794

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00005033 - Trastuzumab in Treating Patients With Recurrent Osteosarcoma | Biotech Hunter | Biotech Hunter